Sangamo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sangamo Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $0.04 | $-0.03 | 233.3 % |
Jun 2024 | 2024-08-06 | $-0.18 | $-0.15 | -20.0 % |
Mar 2024 | 2024-05-09 | $-0.27 | $-0.21 | -28.6 % |
Dec 2023 | 2024-03-13 | $-0.34 | $-0.26 | -30.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $49.41M | $17.94M | 175.4 % |
Jun 2024 | 2024-08-06 | $356.00K | $8.26M | -95.7 % |
Mar 2024 | 2024-05-09 | $481.00K | $6.65M | -92.8 % |
Dec 2023 | 2024-03-13 | $2.04M | $8.10M | -74.8 % |
Sangamo Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3.
Sangamo Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was $0.04, which beat the estimate of $-0.03.
Sangamo Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 12, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.